" laboratory evidence and observational clinical trials suggested that statins may have very favorable effects on the skeleton , " senior investigator dr “实验室证据以及临床研究的观测都提示，他汀类药物可能对骨的作用有良好的作用。 ”
And , secondly : is there significant heterogeneity between the statin treatment effect in primary prevention subgroups compared with that in secondary prevention subgroups 第二：他汀对一级预防群体的治疗效果和二级预防群体的治疗效果之间是否有显著的区别？
Background ? although statins reduce the risk of cardioascular eents , concerns about aderse effects may deter physicians from prescribing these agents 背景：尽管他他汀类药物可以降低心血管事件的风险，但是，对于其不良反应的顾虑，可能阻止医生对此类药物的使用。
A 71 - year - old man was admitted for coronary angiography because of arrhythmia and received clopidogrel ( dosage not stated ) , aspirin , verapamil and statins 1例71岁男性因心律不齐，接受氯吡格雷(剂量不详) 、阿斯匹林、异搏定和他汀类药物治疗，为进行冠状动脉造影术入院。
We performed a systematic oeriew of randomized statin trials to quantify the risks of musculoskeletal , renal , and hepatic complications associated with therapy 我们通过他汀药物随机试验的系统观察，定量研究了与治疗相关的他汀类药物引起的骨骼肌、肾脏以及肝脏的风险。
Doctors say statins are not the only way to lower c . r . p . they say exercise , a healthy diet and stopping smoking also reduce it 医生（强调：好像夸大了）他汀类药物并不是降低c反应蛋白的唯一方法，运动、 （合理节食：应该是合理膳食，并不一定要节食哦）和戒烟也是有效手段。
The guidelines also say new studies show that patients should not stop taking the cholesterol - lowering drugs called statins before surgery , an issue not addressed in earlier versions 指南指出，最新研究显示患者在手术前不应停用他汀类降胆固醇药物，这是以前没有提到的。
Conclusion : statin withdrawal is associated with increased risk of death or dependency at 90 days . hence , this treatment should be continued in the acute phase of ischemic stroke 结论：停止他汀治疗增加90天内死亡与依赖性风险，在缺血性卒中急性期他汀治疗应该一直持续。
Conclusion : this study supports the use of statins in microalbuminuric subjects with the metabolic syndrome to reduce the incidence of major adverse cardiac events 结论：此研究支持将他汀类药物用于治疗患有代谢综合征的微量白蛋白尿受试者，以降低主要不良心血管事件发生率。
Karas and colleagues examined the records of patients treated with popular statins , including pfizer inc . ' s lipitor and merck & co . inc . ' s zocor , now off patent 格拉瑞博士和同事检查服用流行性他汀类药物患者的记录,包括现在还没有药品专利的辉瑞公司的阿托和马瑞克有限公司的舒降之
